Skip to main content
. 2025 Apr 2;12:1571737. doi: 10.3389/fmed.2025.1571737

Table 2.

Performance of the POD for the diagnosis of HCC in training and validation cohort.

Cohort AUC (95% CI) Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Training cohort 0.967 (0.941–0.993) 91.43 96.20 95.52 92.68
Validation cohort 0.955 (0.912–0.999) 90.0 82.0 69.23 95.0

POD, probability of disease; AUC, the area under the ROC curve; HCC, hepatocellular carcinoma; PPV, positive predictive value; NPV, negative predictive value.